Keigo Araki

Hirakata, 5731191, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Should supportive care be started before initiating cancer treatment?

Should supportive care be started before initiating cancer treatment?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 21, 2026

Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.

Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.

Journal: Translational lung cancer research

Published: February 14, 2026

AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

Journal: Molecular therapy. Oncology

Published: January 08, 2026

Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology.

Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology.

Journal: Cancers

Published: December 10, 2025

Murine Embryonic Stem Cells Possess Distinct E2F Activity That Activates Tumor Suppressor Promoter Elements.

Murine Embryonic Stem Cells Possess Distinct E2F Activity That Activates Tumor Suppressor Promoter Elements.

Journal: Genes to cells : devoted to molecular & cellular mechanisms

Published: November 01, 2025

Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells.

Utility of Tumor Suppressor E2F Target Gene Promoter Elements to Drive Gene Expression Specifically in Cancer Cells.

Journal: Cells

Published: October 30, 2025

Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells.

Distinct Regulation of the ARF and TAp73 Tumor Suppressor Genes by the Transcription Factor E2F1 Enables Discrimination of Cancer Cells from Normal Growing Cells.

Journal: Cells

Published: October 30, 2025

Transcriptional Activation Mechanisms and Target Genes of the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.

Transcriptional Activation Mechanisms and Target Genes of the Oncogene Product Tax of Human T-Cell Leukemia Virus Type 1.

Journal: Genes

Published: September 02, 2025

Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.

Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.

Journal: Respiratory investigation

Published: August 22, 2025

The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB.

The Transcriptional Coactivator DEAD/H Box 5 (DDX5) Gene Is a Target of the Transcription Factor E2F1 Deregulated from the Tumor Suppressor pRB.

Journal: Genes

Published: July 13, 2025

DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53.

DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53.

Journal: International journal of molecular sciences

Published: November 06, 2024

The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2.

The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2.

Journal: Biomolecules

Published: September 13, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026